The Expression of FMS, KIT and FLT3 in Hematopoietic Malignancies
Authors:
- Nadine CarbucciaNCNadine Carbuccia
- Olivier RosnetOROlivier Rosnet
- Daniel BirnbaumtDBDaniel Birnbaumt
- 1 January 1994
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 13 (3-4) , 223-227
Abstract
Three receptor molecules, belonging to the class III of receptor tyrosine kinases, namely the receptors for colony-stimulating factor 1, CSF1R (product of the FMS proto-oncogene) and Steel factor, SLFR (product of the KIT proto-oncogene), as well as the recently identified FLT3/FLK2 gene product, appear to play distinct roles in normal hematopoietic differentiation. Their potential role in leukemic hematopoiesis has been approached by expression studies in hematopoietic malignancies, especially in acute leukemias of the myeloid and lymphoid lineages. We present here a review of available data, and discuss the possible significance and potential applications of these results.Keywords
This publication has 25 references indexed in Scilit:
- The Steel factorDevelopmental Biology, 1992
- Of kit and mouse and manCurrent Biology, 1991
- Scratching the surfaceCurrent Biology, 1991
- A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populationsCell, 1991
- Genetic and structural homology of stem cell factor and macrophage colony-stimulating factorCell, 1991
- Isolation and chromosomal localization of a novel FMS-like tyrosine kinase geneGenomics, 1991
- Leukemia and the disruption of normal hematopoiesisCell, 1991
- M-CSF and M-CSF-receptor gene expression in acute myelomonocytic leukemiasLeukemia Research, 1990
- Expression of the macrophage colony-stimulating factor and c-fms genes in human acute myeloblastic leukemia cells.Journal of Clinical Investigation, 1988
- Evidence for the Involvement of GM-CSF and FMS in the Deletion (5q) in Myeloid DisordersScience, 1986